IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rosalind Advisors, Inc.

Q4 2023 Holdings

Filed 2024-02-14 | 30 holdings | $121.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Lyra Therapeutics Inc(LYRA)COM55234L105$9.9M1,888,7208.2%
Myomo Inc-New(MYO)COM NEW62857J201$9.6M1,919,9107.9%
Astria Therapeutics Inc(CATBUSD)COM04635X102$8.7M1,128,7087.1%
Xeris Biopharma Hldgs Inc(XERS)COM98422E103$8.3M3,543,6856.9%
Viridian Therapeutics Inc(VRDN)COM92790C104$7.8M360,3326.5%
Compass Pathways PLC ADR(CMPS)SPONSORED ADS20451W101$7.0M798,5005.8%
Optinose IncCOM68404V100$6.3M4,885,5805.2%
Mediwound Ltd-New(MDWD)SHS NEWM68830112$6.2M606,7515.1%
Madrigal Pharmaceuticals(MDGL)COM558868105$5.8M25,0004.8%
Cellectar Biosciences-New(CLRBUSD)COM NEW15117F807$5.6M2,005,6584.6%
Sarepta Thereapeutics Inc(SRPT)COM803607100$5.5M57,4004.6%
Verona Pharma PLC SPN(VRNA)SPONSORED ADS925050106$5.0M250,0004.1%
Spruce Biosciences IncCOM85209E109$4.6M1,586,3923.8%
Profound Medical Corp-New(PROF)COM NEW74319B502$4.5M533,3333.7%
Delcath Systems, Inc.(DCTH)COM NEW24661P807$4.3M1,038,8283.6%
Kalvista Pharmaceuticals(KALV)COM483497103$3.7M300,0003.0%
Veru Inc(VERUEUR)COM92536C103$2.9M4,000,0002.4%
Inspiremd Inc-New(NSPR)COM45779A846$2.6M925,1942.1%
Trevi Therapeutics Inc(TRVI)COM89532M101$2.5M1,862,4252.1%
Ascendis Pharma A/S ADR(ASND)SPONSORED ADR04351P101$2.1M16,8001.7%
Fortress Biotech Inc-New(FBIO)COM NEW34960Q307$1.8M607,7971.5%
Envveno Medical CorpCOM29415J106$1.6M312,0911.3%
Reviva Pharmaceuticals(RVPH)COM76152G100$1.0M196,3000.8%
Sarepta Therapeutics IncPutPUT803607950$832.3K57,4000.7%
Merrimack Pharmaceut-New(MACKEUR)COM NEW590328209$804.6K60,0000.7%
Invesco QQQ TRPutUNIT SER 146090E953$602.0K900,0000.5%
Acelrx Pharmaceutical-New(TLPH)COM NEW00444T209$557.8K758,9660.5%
Spdr SER TR(XBI)PutS&P BIOTECH78464A870$465.0K500,0000.4%
Geron Corp(GERN)COM374163103$422.0K200,0000.3%
Tonix Pharma Hldg Crp-NewCOM NEW890260854$363.1K900,9000.3%